Item 4. Controls and Procedures.
4K characters. Original on sec.gov ·
Item 4. Controls and Procedures.
Controls and Procedures.
We,
under the
supervision and
with the
participation of
our management,
including our
Chief Executive
Officer and
Chief Financial
Officer,
have
evaluated
the
effectiveness
of
the design
and
operation
of
our
disclosure
controls
and
procedures
(as
defined
in
Rule
13a-15(e)
under
the
Securities
Exchange
Act
of
1934).
Based
on
our
evaluation,
our
Chief
Executive
Officer
and
Chief
Financial
Officer have
concluded that,
as of
August 24,
2025, our
disclosure controls
and procedures
were effective
to ensure
that information
required to
be disclosed
by us
in reports
that we file
or submit
under the
Securities Exchange
Act of
1934 is (1)
recorded, processed,
summarized,
and
reported
within
the
time
periods
specified
in
Securities
and
Exchange
Commission
rules
and
forms,
and
(2)
accumulated and
communicated to
our management,
including our
Chief Executive
Officer and
Chief Financial
Officer,
in a
manner
that allows timely decisions regarding required disclosure.
There were no changes in our internal
control over financial reporting (as defined
in Rule 13a-15(f) under the Securities Exchange
Act
of 1934)
during the
quarter ended
August 24,
2025, that
materially affected,
or are reasonably
likely to
materially affect,
our internal
control over financial reporting.
PART
II.
OTHER INFORMATION
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
The
following
table
sets forth
information
with
respect
to
shares
of
our
common
stock
that we
purchased
during
the quarter
ended
August 24, 2025:
Period
Total
Number
of Shares
Purchased (a)
Average
Price Paid
Per Share (b)
Total
Number of Shares
Purchased as Part of a Publicly
Announced Program (c)
Maximum Number of Shares
that may yet be Purchased
Under the Program (c)
May 26, 2025 -
June 29, 2025
-
$
-
-
36,918,163
June 30, 2025 -
July 27, 2025 (d)
7,520,212
49.92
7,520,212
29,397,951
July 28, 2025 -
August 24, 2025 (d)
1,199,631
50.41
1,199,631
28,198,320
Total
8,719,843
$
49.99
8,719,843
28,198,320
(a)
The total number
of shares purchased
includes shares of
common stock withheld
for the payment
of withholding taxes
upon the distribution
of
deferred option units.
(b)
Excludes commissions paid and other costs of execution, including excise taxes.
(c)
On June
27, 2022,
our Board
of Directors approved
an authorization
for the
repurchase of
up to
100,000,000 shares of
our common stock
and
terminated the
prior authorization.
Purchases can
be made
in the
open market
or in
privately negotiated
transactions, including
the use
of call
options
and
other
derivative
instruments,
Rule
10b5-1
trading
plans,
and
accelerated
repurchase
programs.
The
Board
did
not
specify
an
expiration date for the authorization.
(d)
In the
first quarter
of fiscal
2026, we
entered into
two accelerated
share repurchase
(ASR) agreements
with an
unrelated third-party
financial
institution to repurchase an aggregate of $500.0 million of our
shares. We paid
an aggregate of $500.0 million and received an initial delivery of
7.5 million
shares of
our common stock
based on
the closing
share price of
our common
stock on July
1, 2025.
The value
of the
initial shares
delivered under the
ASR agreements represented 80
percent of the
aggregate purchase price,
with a fair value
of $400.0 million.
The first ASR
agreement was
settled on
August 4,
2025, with
a final
delivery of
1.2 million
additional shares.
The final
average purchase
price for
the first
ASR
agreement
was
$50.41
per
share,
not
including
costs
of
execution
or
excise
tax.
The
final
settlement
of
the
second
ASR
agreement
occurred on August
29, 2025, during
the second quarter
of fiscal 2026,
with a final
delivery of 1.3
million additional shares.
The final average
purchase price for the second ASR agreement was $49.45 per share, not including costs of execution or excise tax.
Previous: Item 3. Quantitative and Qualitative Disclosures About Market Risk. · Next: Item 5. Other Information.